---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-25-016089"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:26:32.739890+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb refinances $2.8B term loans; margin cut, maturity extended to 2031

## Summary
- $2.802B new Replacement Term Loans to refinance existing term B loans due 2028 and 2031.
- Applicable margin reduced by 0.50% (to 3.75%+SOFR) for Third Amendment loans and 0.25% (to 2.75%+ABR) for First Incremental loans.
- Maturity extended for First Incremental loans from Sep 29, 2028 to Jan 15, 2031; Third Amendment loans unchanged at 2031.
- Transaction expected to close in Q1 2026, subject to conditions; no assurance of completion.

## SEC filing metadata
- accession: 0000950103-25-016089
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000095010325016089/0000950103-25-016089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000095010325016089/dp238710_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-25-016089
- JSON: https://secwatch.observer/filing/0000950103-25-016089.json
- Plain text: https://secwatch.observer/filing/0000950103-25-016089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.